A company developing a treatment for Covid-19 infections taken as a tablet instead of infusion issued its initial public offering, or IPO, for common stock. . . . → Read More: Covid-19 Drug Biotech Raises $300M in IPO
|
|||||
|
       
  |
Global drug maker Novartis is gaining access to two Covid-19 therapy candidates made from a library of synthetic protein components. . . . → Read More: Novartis Gains Synthetic Protein Therapies for Covid-19 
Partial results from a clinical trial show a drug to stop specific cancer-causing proteins shrinks advanced tumors in some patients across several tumor types. . . . → Read More: Precision Drug Trial Shows Solid Tumor Shrinkage 
Global drug maker Roche Group is acquiring an experimental antiviral therapy for Covid-19 infections taken as a oral drug, rather than an infusion. . . . → Read More: Roche Gains Covid-19 Oral Drug Candidate 
A biotechnology company creating synthetic viruses with artificial intelligence to deliver gene therapies is licensing its technology to drug maker Roche. . . . → Read More: Gene Therapy Delivery Tech Licensed in $1.8B Deal  One comment - (Comments are closed)  Intellectual property  biomedical, biotechnology, entrepreneurs, genomics, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, university 
A company developing techniques to deliver vaccines like Covid-19 with a nasal spray received an opportunity to license the process from University of Houston. . . . → Read More: Start-Up Gains Access to Vaccine Nasal Spray Technology Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, Covid-19, engineering, entrepreneurs, licensing, life sciences, pharmaceuticals, physical sciences, preclinical, university 
A new enterprise is creating thin films for vaccines, including Covid-19, to make possible their mass production and distribution at room temperatures. . . . → Read More: Start-Up Developing Thin Films for Vaccine Delivery Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, Covid-19, engineering, entrepreneurs, licensing, life sciences, manufacturing, pharmaceuticals, physical sciences, university 
Dexcom Inc., a maker of glucose monitoring systems, and University of Virginia are collaborating on extending the company’s current technologies to cover more types of diabetes . . . → Read More: Dexcom, UVirginia Partner on Diabetes Technology Comments are closed Joint ventures/collaborations biomedical, engineering, entrepreneurs, licensing, life sciences, mathematics, medical device, software, university 
A biotechnology company is sponsoring university research on light waves reacting in characteristic patterns for detecting SARS-CoV-2 viruses by a smartphone camera. . . . → Read More: Univ Lab, Company Developing Phone-Based Virus Sensor One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, Covid-19, engineering, licensing, life sciences, medical device, nanotechnology, physical sciences, physics, software, university 
The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus. . . . → Read More: DoD Funding Variable Covid-19 Vaccine Technology One comment - (Comments are closed) Finance, New products biomedical, biotechnology, contract, Covid-19, DoD, licensing, life sciences, manufacturing, pharmaceuticals |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||